⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

Agilent added one new risk disclosure focused on artificial intelligence development and deployment, reflecting emerging regulatory and competitive concerns in this technology area. Four existing risk disclosures were substantively modified, including updates to tax liability exposure, debt management implications, and public health crisis impacts, suggesting the company refined its risk characterization in these areas. The overall risk factor structure remained largely stable with 29 risks carried forward unchanged from 2023.

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

🟢 New in Current Filing Issues in the development, deployment, and use of artificial intelligence technologies in our business operations, services and products may result in reputational harm, regulatory action, or legal liability, and any failure to adapt to such technological developments or industry trends could adversely affect the competitiveness of our business. 🔒

🟡 Modified Changes in tax laws, unfavorable resolution of tax examinations, or exposure to additional tax liabilities could have a material adverse effect on our results of operations, financial condition and liquidity. 🔒

🟡 Modified We have outstanding debt and may incur other debt in the future, which could adversely affect our financial condition, liquidity and results of operations. 🔒

🟡 Modified Public health crises such as the COVID-19 pandemic may adversely impact, and pose risks to, certain elements of our business, results of operations and financial condition, the nature and extent of which are highly uncertain and unpredictable. 🔒

🟡 Modified Some of our products are subject to particularly complex regulations such as regulations of toxic substances, and failure to comply with such regulations could harm our business. 🔒

5 changes in this historical filing

Historical year-over-year comparisons (2024 vs 2023 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →